Geode Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History

Geode Capital Management, LLC

$1.07 Trillion
Q1 2024

A detailed history of Geode Capital Management, LLC transactions in Atea Pharmaceuticals, Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 1,882,480 shares of AVIR stock, worth $6.91 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,882,480

Previous 1,807,912 4.12%

Holding current value

$6.91 Million

Previous $5.51 Million 37.92%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	BUY	$3.09 - $4.56 $230,415 - $340,030	74,568 Added 4.12%	1,882,480 $7.61 Million
Q4 2023 Feb 13, 2024	BUY	$2.8 - $3.35 $230,112 - $275,313	82,183 Added 4.76%	1,807,912 $5.51 Million
Q3 2023 Nov 13, 2023	BUY	$3.0 - $3.79 $242,073 - $305,818	80,691 Added 4.91%	1,725,729 $5.18 Million
Q2 2023 Aug 11, 2023	BUY	$3.21 - $5.06 $497,466 - $784,168	154,974 Added 10.4%	1,645,038 $6.15 Million
Q1 2023 May 15, 2023	BUY	$3.0 - $4.97 $158,115 - $261,943	52,705 Added 3.67%	1,490,064 $4.99 Million

Q4 2022 Feb 13, 2023	BUY	$4.35 - $6.17 $209,478 - $297,122	48,156 Added 3.47%	1,437,359 $6.91 Million
Q3 2022 Nov 14, 2022	BUY	$5.49 - $8.79 $1.25 Million - $2 Million	227,779 Added 19.61%	1,389,203 $7.9 Million
Q2 2022 Aug 12, 2022	BUY	$5.33 - $8.18 $707,099 - $1.09 Million	132,664 Added 12.9%	1,161,424 $8.25 Million
Q1 2022 May 13, 2022	SELL	$5.5 - $9.19 $286,181 - $478,183	-52,033 Reduced 4.81%	1,028,760 $7.43 Million
Q4 2021 Feb 11, 2022	BUY	$7.67 - $44.59 $369,670 - $2.15 Million	48,197 Added 4.67%	1,080,793 $9.66 Million
Q3 2021 Nov 12, 2021	BUY	$21.33 - $35.06 $7.58 Million - $12.5 Million	355,543 Added 52.51%	1,032,596 $36.2 Million
Q2 2021 Aug 13, 2021	BUY	$19.22 - $59.08 $7.73 Million - $23.8 Million	402,168 Added 146.3%	677,053 $14.5 Million
Q1 2021 May 12, 2021	BUY	$41.42 - $88.44 $290,726 - $620,760	7,019 Added 2.62%	274,885 $17 Million
Q4 2020 Feb 12, 2021	BUY	$26.36 - $41.78 $7.06 Million - $11.2 Million	267,866 New	267,866 $11.2 Million

Others Institutions Holding AVIR

# of Institutions

119

Shares Held

49.6M

Call Options Held

108K

Put Options Held

327K

View Full List

About Atea Pharmaceuticals, Inc.

Ticker AVIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,258,600
Market Cap $306M
Description
Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focused on discovering, developing, and commercializing antiviral therapeutics for patients suffering from viral infections. Its lead product candidate is AT-527, an antiviral drug candidate that is in Phase II clinical trial for the treatment of patients with COVID-19. The ...

More about AVIR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Atea Pharmaceuticals, Inc. Transaction History